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Introduction
Aliphatic polyesters, for example copolymers of L-lactide 
and glycolide (PLGA), are very attractive materials to be 
processed into temporary scaffolds for bone and cartilage
tissue engineering [1,2]. Several experiments performed 
in our group showed that the PLGA scaffolds support 
growth and differentiation of osteogenic cells [3,4] and 
are biocompatible with soft tissue in the animal model [5]. 
Besides, numerous studies confi rmed that surface modi-
fi cation strategies with the use of inorganic phases (e.g. 
calcium phosphates) or biomolecules (e.g. collagens, 
glycosaminoglycans) may provide additional benefi cial ef-
fect on bone tissue healing and regeneration [6]. However, 
in the case of 3D porous scaffolds it is diffi cult to depose
homogenous layer of inorganic/organic phases on the pore
walls within the whole volume of the scaffolds. It results from 
relatively high surface area, turtuosity of the pores and dif-
fusion-limited phenomena. Therefore particular strategies
have to be applied to modify the complete volume of the
scaffolds. In our approach we use vacuum to remove air from 
the pores and thus to enhance the modifi cation solution to 
penetrate all pores.
The aim of this study was to: i) modify the entire volume 
of the PLGA scaffolds with hydrohyapatite (HAP) or col-
lagen, and ii) fi nd out if applied modifi cations are benefi cial 
for the healing process in critical-size osteochondral defects 
in rabbits.
Materials and methods
Scaffolds manufacturing, modifi cation and characteri-
zation
PLGA with molar ratio of L-lactide to glycolide 85:15 
(Mn=100 kDa, d=2.1) was synthesized according to 
a method described previously [7]. Cylindrical porous scaf-
folds (diameter 4 mm, height 5 mm) were obtained by an
innovative solvent casting/salt particulate leaching method
[4]. The size of the salt particles was 250-320 μm and their 
volume fraction was 85%. The scaffolds were modifi ed with 
hydroxyapatite (HAP) by incubation in simulated body fl uid
(SBF) for 12 days [8] and with collagen (type I, bovine origin,
Sigma) by soaking the scaffolds in collagen solution (40 μg/
ml) for 24h. Modifi cation media (i.e. SBF or collagen solution)
were forced to penetrate the whole volume of the scaffolds
by applying a vacuum. Afterwards the scaffolds were washed
3 times in tap water (in the case of SBF modifi cation) and in
UHQ water (in the case of collagen adsorption).
The scaffolds were characterized by scanning electron
microscopy (Nova NanoSEM, FEI) equipped with EDS
analyzer, FTIR spectroscopy (FTS Digilab, BioRad) and
X-ray diffractometry (XRD, Panalytical X′Pert Pro system).
Scaffolds in vivo evaluation in New Zealand rabbit
model
The research protocol was approved by Local Ethic
Committee (University of Natural Science, Lublin, Poland,
No 43/2008; 01 July 2008). Three types of scaffolds: without
modifi cation (PLGA), enriched with collagen (PLGA/coll) and
enriched with hydroxyapatite (PLGA/HAp) were sterilized
with oxygen peroxide plasma (Sterrad 120, ASP, J&J).
Sham operation (defect created and but not fi lled with a
scaffold) acted as control. Six animals were used in this
study, i.e. both knees of the animals were operated.
General anesthesia
The mixture of xylazine and ketamine was administered 
by intramuscular injection (5 mg/kg xylazine and 35 mg/
kg ketamine). The state of sedation and analgesia were
achieved. The surgical site was prepared, the area surround-
ing the knee joint was shaved, and a venfl on was placed into
the marginal ear vein (v. auricularis marginalis). After 10 min
general anesthesia was induced by intravenous administra-
tion of ketamine. To maintain the anesthesia ketamine was 
used as a continuous intravenous infusion using an infusion
pump at a dose of 0.5 mg/kg/min.
Knee arthrotomy 
Approach to the knee was obtained by making an incision
on the side of the knee. The incision began at about Ľ  distal
part of femur to achieve a level 2 cm below the tibial tuberos-
ity. The tissues were prepared along the same incision line,
fascia lata was cut laterally on the block of the knee, then
straight along the patellar ligament at a distance of about 7 
mm from it, and then the capsule of the knee was cut. Patella
with vastus lateralis muscle was moved medially – showing
the surface of the femoral trochlea (FIG.1 A).
Scaffolds’ implantation
In the middle of the trochlear groove of the femur a round
hole in the shape of a cylinder with a diameter of 4 mm and
a depth of 5 mm, covering the subchondral layer was cre-
ated for the implant (FIG.1B). The hole was fl ushed with 
isotonic solution of NaCl 0.9%. In the prepared place the
scaffold was inserted (FIG.1C,D). Tissues were apposed in
layers anastomosed with absorbable sutures (Polyglactine 
910, 3/0) according to anatomical alignment (FIG.1E). Non-
absorbable suture material (Polyamide, 3/0) was used on
the apposed skin (FIG.1F).
Postoperative management
After recovery rabbits were able to freely move  in the
cages. Medication with analgesic was administered (butor-
phanol at a dose of 0.1 mg/kg). Sul-Tridin 24% was also
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once a day for fi ve days. After ten days
skin sutures were removed.
Postoperative observation  
During the post operative time
most of the animals revealed no
signs of knee dysfunction. Within 2-3 
days after surgery individual animals
showed lameness of the fi rst degree,
which had no signifi cant effect on the 
general condition of the animals. One
rabbit in the study group (without any 
scaffold) showed a signifi cant swelling
of the knee sustained in a week after 
surgery. This rabbit showed a first
degree lameness with limited range
of motion at the stifl e joint. After the
euthanasia it was determined that the
joint had infl ammation, an increased
amount of synovial fluid, and de-
generative changes that signifi cantly 
deformed  the surface of the joint and
were the cause of the clinical changes
described in the functioning of the joint.
Euthanasia
After four weeks from the operation the rabbits were 
introduced into a state of general anesthesia with xy-
lazine and ketamine. After reaching deep anesthesia 
euthanasia was performed by intracardiac injection of 
sodium pentobarbital. Then, the distal femoral epiphyses 
were excised, placed in 4% formalin and collected for 
further testing.
Cone Beam Computed tomography (CBCT) 
The CBCT evaluations of the femora were carried 
out on GXCB-500/i-CAT (Gendex Dental System, 
Italy) volumetric tomograph at an isometric voxel size of 
125x125x125 μm3 and total scanning time of 23 s. Data 
acquisition and treatment was performed on iCAT Vision 
program working in DICOM standard. 
Histology
The formalin from rabbit distal femoral epiphyses was 
removed by washing the specimens in tap water for two 
days. As a decalcifi cation agent hydro-
chloric acid (TBD-1 Rapid decalcifi er,
Thermo Shandon Ltd, UK) was used
for 5 days. After that the specimens
were immersed in graded ethanol
series for 24h each and twice for 1h 
in xylene. Finally, the samples were
bathed in liquid Histoplast paraffi n at
56oC for 3 days, and then embedded
in a fresh portion. The embedded par-
affi n blocks were cut by rotary micro-
tome (RM 2145, Leica Microsystems,
Germany) for 9-μm thick sections.
After deparafi nization of tissue slices
in xylene and rehydratation in ethanol 
series the specimens were stained with Masson-Goldner 
trichrome according to standard procedure, dehydrated
again and mounted in universal histological mounting 
medium.
Results and discussion
The goal of this study was to modify entire volume 
of the PLGA scaffolds with natural bone extracellular 
matrix components, i.e. collagen type I and hydroxyapatite 
with the aim to enhance healing/regeneration of tissues in 
experimentally created osteochondral defects in rabbits. 
FIG. 2 shows the microstructure of the scaffolds regis-
tered under scanning electron microscope. The scaffolds 
had interconnected pores of a size close to the size of 
porogen particles used in the process of their preparation, 
i.e. 250–320 μm. PLGA/coll scaffolds looked similar to the 
scaffolds without modifi cation, but EDS analysis revealed 
presence of 2.5% of nitrogen originating from collagen. In 
PLGA/HAp scaffolds pore walls were more rough due to 
mineral deposits. Under higher magnifi cations, i.e. 4000x,
round caulifl ower-shape forms on the pore walls were vis-
ible in the scaffolds submitted to incubation in SBF (FIG. 
1C, insert). EDS analysis confi rmed that on PLGA scaf-
folds after contact with SBF calcium and phosphorus were 
detected and Ca/P ratio was 1.6, which is similar to that 
of hydroxyapatite. The FTIR and XRD examinations also 
confi rmed presence of fi ne-crystalline hydroxyapatite phase 
(data not presented). The same results were observed on 
the scaffolds surfaces as well as in the cross-sections, what 
proves that the entire volume of the scaffolds was modifi ed 
with collagen or hydroxyapatite.
In the fi rst column of FIG. 3A digital camera pictures of 
intact femoral trochlea, trochleas with experimental defects 
fi lled with the scaffolds (PLGA, PLGA/coll, PLGA/HAP) as 
well as empty defect after 4 weeks from the surgery are 
presented. In all specimens the area where the defect was 
created was clearly distinguishable and hyaline cartilage
was not healed. Cone beam computed tomography exami-
nations in 3D projection (FIG. 3B) show that the defects were 
not totally fi lled with mineralized tissue, however 2D cross-
FIG. 1. Surgical procedure of scaffolds implantation into rabbit femoral tro-
chlea: A – exposed surface of femoral trochlea, B – drilled hole in the middle
of the trochlear groove, C– placing the scaffold, D – osteochondral defect fi l-
led with the scaffold, E – tissues apposed with absorbable sutures, F – skin
apposed with non-absorbable sutures.
FIG. 2. SEM microphotographs of PLGA scaffolds non-modifi ed (A), colla-
gen- (B) and HAP-modifi ed (C), original magnifi cation 350x; insert 4000x.
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sections (FIG. 3C) show that the widths of the defect treated 
with PLGA/HAP and PLGA were much smaller than those of 
empty defect and treated with PLGA/coll scaffold. It suggests 
that PLGA scaffolds were benefi cial for bone ingrowth and 
presence of hydroxyapatite enhanced this process.
Histological picture (FIG. 3D, fi rst panel) shows typical 
structure of intact femoral trochlea. Thanks to trichrome 
Masson-Goldner staining the light green hyaline cartilage
was visible on the top. Below it there was trabecular bone: 
stained in light green mature bone matrix, whereas the 
osteoid was coloured red. In the empty defect only fi brous
tissue was visible (FIG. 3D, last panel). Interestingly, pres-
ence of scaffolds clearly enhanced bone/cartilage tissue 
regeneration. The best results were achieved for PLGA/HAP 
and PLGA scaffolds, where the ingrowth of newly formed 
trabeculae started from the peripheries toward center of the 
defects. The more developed hyaline cartilage was visible
for PLGA/HAP scaffolds. Bone and cartilage healing seemed 
to be retarded on PLGA/coll, probably due to higher infl am-
matory response to the collagen of bovine origin.  
Conclusions
In summary, the results show that PLGA scaffolds with 
defi ned microstructure (porosity and pore size) can be 
modifi ed with a thin layer of collagen type I. Moreover in 
the entire volume of the scaffolds hydroxyapatite deposits 
can be created via biomimetic method. The in vivo experi-
ments in rabbit model showed that bone formation was more 
advanced in the case of the scaffolds enriched with HAP. In
the case of PLGA/coll scaffolds the extent of infl ammation 
in surrounding tissues was much higher and healing was 
delayed as compared to non-modifi ed PLGA scaffolds. 
Histological observations show that the
presence of PLGA scaffolds is critical for the 
regeneration of osteochondral defects made
in the knee of rabbits. In a sham operated
knees the regeneration process was limited 
and the defects were fi lled with fi brous con-
nective tissue instead of hyaline cartilage and
bone tissue. CBCT examinations showed that
bone mineralization was more advanced in 
the defects treated with PLGA/HAP scaffolds.
In brief, the results demonstrate that the
PLGA scaffolds enriched with HAP have the
highest potential for the treatment of critical-
size osteochondral defects in rabbits.
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FIG. 3. Macroscopic appearance – A, CBCT-3D reconstruction – B, CBCT
cross-section – C and histological examination – D of rabbit femoral tro-
chlea without the surgery and after 4 weeks from the surgery treated
with scaffolds: PLGA, PLGA/coll and PLGA/HAP as well as sham opera-
tion – empty defect; Masson-Goldner staining.
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